Takahiro Komori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Takahiro Komori has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Kazuomi Kario
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
11 shared publications Ayako Yokota
Division of Cardiovascular Medicine, Department of Medicine Jichi Medical University School of Medicine Tochigi Japan
4 shared publications- Satoshi Hoshide
Jichi Medical University School of Medicine, Tochigi, Japan
4 shared publications Takafumi Okuyama
Division of Cardiovascular Medicine, Department of Medicine Jichi Medical University School of Medicine Tochigi Japan
4 shared publications- Tomonori Watanabe
Division of Cardiovascular Medicine, Department of Medicine Jichi Medical University School of Medicine Tochigi Japan
4 shared publications - Tomoyuki Kabutoya
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
4 shared publications
Latest Publications
- 30 June 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (10) , 2183-2192
Relationship Between Nonuniform Isochrone‐Area in Late Activation Mapping and Arrhythmogenic Substrates Related to Atrial Fibrillation
Introduction: Arrhythmogenic substrates within the atrial myocardium may contribute to the initiation of atrial fibrillation (AF). The relationship between nonuniform isochrone‐areas in late activation mapping and arrhythmogenic substrates remains undetermined. Methods: Sixty‐two patients (66 ± 10 years, 47 males, non‐paroxysmal AF [ n = 30], second ablation procedure [ n = 8]) who undergoing catheter ablation for AF were enrolled. High‐density left atrial (LA) activation mapping was performed during atrial pacing after pulmonary vein (PV) isolation. Late activation mapping was retrospectively reconstructed. Nonuniform isochrone‐areas were defined as regions of nonuniform and mottled conduction‐zones characterized by the crowding of ≥ 3 color‐isochrones within a 1‐cm radius in late activation mapping. The relationship between nonuniform isochrone‐areas and arrhythmogenic substrates associated with AF was evaluated. Results: Non‐PV triggers were identified in 11 patients (AF‐triggers:12; short runs of premature atrial complexes:4), located in the LA wall (posterior:7; anterior:6; septum:2; roof:1). Patients with non‐PV triggers had significantly more nonuniform isochrone‐areas than those without (median [interquartile range] 5.0 [3.0–6.0] vs. 2.0 [1.0–4.0], p < 0.001). In multivariate logistic analysis for the presence of non‐PV triggers, after adjusting for confounders such as non‐paroxysmal AF, heart failure‐history, and presence of low‐voltage areas, the presence of nonuniform isochrone‐areas on the LA low‐posterior wall was an independent indicator for the presence of non‐PV triggers (odds ratio: 6.9 [95% CI:1.1–44.1], p = 0.040). Of the 52 nonuniform isochrone‐areas observed in the 11 patients with non‐PV triggers, 20 areas corresponded to non‐PV trigger sites. Conclusion: Identification of nonuniform isochrone‐areas located on LA low‐posterior wall in late activation mapping may indicate the potential source for non‐PV triggers.
- 30 June 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (10) , 2183-2192
Relationship Between Nonuniform Isochrone‐Area in Late Activation Mapping and Arrhythmogenic Substrates Related to Atrial Fibrillation
Introduction: Arrhythmogenic substrates within the atrial myocardium may contribute to the initiation of atrial fibrillation (AF). The relationship between nonuniform isochrone‐areas in late activation mapping and arrhythmogenic substrates remains undetermined. Methods: Sixty‐two patients (66 ± 10 years, 47 males, non‐paroxysmal AF [ n = 30], second ablation procedure [ n = 8]) who undergoing catheter ablation for AF were enrolled. High‐density left atrial (LA) activation mapping was performed during atrial pacing after pulmonary vein (PV) isolation. Late activation mapping was retrospectively reconstructed. Nonuniform isochrone‐areas were defined as regions of nonuniform and mottled conduction‐zones characterized by the crowding of ≥ 3 color‐isochrones within a 1‐cm radius in late activation mapping. The relationship between nonuniform isochrone‐areas and arrhythmogenic substrates associated with AF was evaluated. Results: Non‐PV triggers were identified in 11 patients (AF‐triggers:12; short runs of premature atrial complexes:4), located in the LA wall (posterior:7; anterior:6; septum:2; roof:1). Patients with non‐PV triggers had significantly more nonuniform isochrone‐areas than those without (median [interquartile range] 5.0 [3.0–6.0] vs. 2.0 [1.0–4.0], p < 0.001). In multivariate logistic analysis for the presence of non‐PV triggers, after adjusting for confounders such as non‐paroxysmal AF, heart failure‐history, and presence of low‐voltage areas, the presence of nonuniform isochrone‐areas on the LA low‐posterior wall was an independent indicator for the presence of non‐PV triggers (odds ratio: 6.9 [95% CI:1.1–44.1], p = 0.040). Of the 52 nonuniform isochrone‐areas observed in the 11 patients with non‐PV triggers, 20 areas corresponded to non‐PV trigger sites. Conclusion: Identification of nonuniform isochrone‐areas located on LA low‐posterior wall in late activation mapping may indicate the potential source for non‐PV triggers.
- Open Access
- 7 April 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (2)
Predicting Transmural Lesion Formation and Steam‐Pop Occurrence During Bipolar Ablation—Ex Vivo Porcine Model
Background: Bipolar radiofrequency (RF) ablation can create deeper myocardial lesions than unipolar ablation, yet its optimal settings remain undefined. Objective: To develop and validate predictive models for lesion transmurality and steam‐pop occurrence during bipolar ablation. Methods: Ex vivo bipolar ablation was applied to porcine myocardium (5–20 mm thickness) with catheters placed bilaterally at 45‐degree and 10‐g contact‐force. RF power (20–50 W) and duration (20–180 s) were systematically varied. Generalized linear models (GLM) were trained on 194 applications to predict transmurality and steam‐pop from RF energy, tissue thickness, initial bipolar impedance, 5‐s impedance drop (absolute and percentage [PercentImpDrop5]), and RF duration; 111 independent applications served as the validation. Results: Training yielded 95 transmural lesions (49%) and 11 steam‐pops (5.7%). For transmurality, the model incorporating RF energy, RF duration, initial impedance, and tissue thickness achieved an area under the receiver‐operating characteristics curve (AUC) of 0.95 (95% CI 0.91–0.99) with 88% sensitivity and 100% specificity. Omitting tissue thickness markedly degraded performance (AUC 0.68; DeLong, p = 0.003). For steam‐pop, the model combining RF energy and PercentImpDrop5 showed the best discrimination (AUC 0.90 [0.82–0.97], sensitivity 84%, specificity 90%); notably, PercentImpDrop5 alone achieved comparable accuracy (AUC 0.89). Conclusion: Tissue thickness is the dominant determinant of transmural lesion formation, whereas early impedance drop serves as a reliable real‐time indicator of steam‐pop risk during bipolar RF ablation. These algorithms may help standardize bipolar ablation protocols by enabling prospective titration of energy delivery based on tissue characteristics and intraprocedural impedance monitoring.
- 7 April 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (2)
Open AccessPredicting Transmural Lesion Formation and Steam‐Pop Occurrence During Bipolar Ablation—Ex Vivo Porcine Model
Background: Bipolar radiofrequency (RF) ablation can create deeper myocardial lesions than unipolar ablation, yet its optimal settings remain undefined. Objective: To develop and validate predictive models for lesion transmurality and steam‐pop occurrence during bipolar ablation. Methods: Ex vivo bipolar ablation was applied to porcine myocardium (5–20 mm thickness) with catheters placed bilaterally at 45‐degree and 10‐g contact‐force. RF power (20–50 W) and duration (20–180 s) were systematically varied. Generalized linear models (GLM) were trained on 194 applications to predict transmurality and steam‐pop from RF energy, tissue thickness, initial bipolar impedance, 5‐s impedance drop (absolute and percentage [PercentImpDrop5]), and RF duration; 111 independent applications served as the validation. Results: Training yielded 95 transmural lesions (49%) and 11 steam‐pops (5.7%). For transmurality, the model incorporating RF energy, RF duration, initial impedance, and tissue thickness achieved an area under the receiver‐operating characteristics curve (AUC) of 0.95 (95% CI 0.91–0.99) with 88% sensitivity and 100% specificity. Omitting tissue thickness markedly degraded performance (AUC 0.68; DeLong, p = 0.003). For steam‐pop, the model combining RF energy and PercentImpDrop5 showed the best discrimination (AUC 0.90 [0.82–0.97], sensitivity 84%, specificity 90%); notably, PercentImpDrop5 alone achieved comparable accuracy (AUC 0.89). Conclusion: Tissue thickness is the dominant determinant of transmural lesion formation, whereas early impedance drop serves as a reliable real‐time indicator of steam‐pop risk during bipolar RF ablation. These algorithms may help standardize bipolar ablation protocols by enabling prospective titration of energy delivery based on tissue characteristics and intraprocedural impedance monitoring.
- Open Access
- 9 February 2024
- Published by Wiley in Journal of Arrhythmia
- Vol. 40 (2) , 363-373
Relationship between the atrial‐activation pattern around the triangle of Koch and successful ablation sites in slow‐fast atrioventricular nodal reentrant tachycardia
Background: The precise details of atrial activation around the triangle of Koch (ToK) remain unknown. We evaluated the relationship between the atrial‐activation pattern around the ToK and success sites for slow‐pathway (SP) modification ablation in slow‐fast atrioventricular reentrant tachycardia (AVNRT).Methods: Thirty patients with slow‐fast AVNRT who underwent successful ablation were enrolled. Atrial activation around the ToK during sinus rhythm was investigated using ultra‐high‐density mapping pre‐ablation. The relationships among features of atrial‐activation pattern and success sites were examined.Results: Of 30 patients (22 cryoablation; 8 radiofrequency ablation), 26 patients had a collision site of two wavefronts of delayed atrial activation within ToK, indicating a success site. The activation‐search function of Lumipoint software, which highlights only atrial activation with a spatiotemporal consistency, showed non‐highlighted area on the tricuspid‐annulus side of ToK. In 23 of the patients, a spiky potential was recorded at that collision site outside the Lumipoint‐highlighted area. Fifteen cryoablation patients with a success site coincident with a collision site outside the Lumipoint‐highlighted area had significantly more frequent disappearances of SP after initial cryoablation (46.7% vs. 0%, p = .029), fewer cryoablations (3.7 ± 1.8 vs. 5.3 ± 1.3, p = .045), and shorter procedure times (170 ± 57 vs. 228 ± 91 min, p = .082) compared to the seven cryoablation patients without such sites. Four patients had transient AV block by ablation inside the Lumipoint‐highlighted area with fractionated signals, but no patient developed permanent AV block or recurrence post‐procedure (median follow‐up: 375 days).Conclusions: SP modification ablation at the collision site of atrial activation of the tricuspid‐annulus side along with a spiky potential could provide a better outcome.
- 9 February 2024
- Published by Wiley in Journal of Arrhythmia
- Vol. 40 (2) , 363-373
Open AccessRelationship between the atrial‐activation pattern around the triangle of Koch and successful ablation sites in slow‐fast atrioventricular nodal reentrant tachycardia
Background: The precise details of atrial activation around the triangle of Koch (ToK) remain unknown. We evaluated the relationship between the atrial‐activation pattern around the ToK and success sites for slow‐pathway (SP) modification ablation in slow‐fast atrioventricular reentrant tachycardia (AVNRT).Methods: Thirty patients with slow‐fast AVNRT who underwent successful ablation were enrolled. Atrial activation around the ToK during sinus rhythm was investigated using ultra‐high‐density mapping pre‐ablation. The relationships among features of atrial‐activation pattern and success sites were examined.Results: Of 30 patients (22 cryoablation; 8 radiofrequency ablation), 26 patients had a collision site of two wavefronts of delayed atrial activation within ToK, indicating a success site. The activation‐search function of Lumipoint software, which highlights only atrial activation with a spatiotemporal consistency, showed non‐highlighted area on the tricuspid‐annulus side of ToK. In 23 of the patients, a spiky potential was recorded at that collision site outside the Lumipoint‐highlighted area. Fifteen cryoablation patients with a success site coincident with a collision site outside the Lumipoint‐highlighted area had significantly more frequent disappearances of SP after initial cryoablation (46.7% vs. 0%, p = .029), fewer cryoablations (3.7 ± 1.8 vs. 5.3 ± 1.3, p = .045), and shorter procedure times (170 ± 57 vs. 228 ± 91 min, p = .082) compared to the seven cryoablation patients without such sites. Four patients had transient AV block by ablation inside the Lumipoint‐highlighted area with fractionated signals, but no patient developed permanent AV block or recurrence post‐procedure (median follow‐up: 375 days).Conclusions: SP modification ablation at the collision site of atrial activation of the tricuspid‐annulus side along with a spiky potential could provide a better outcome.
- 26 September 2023
- Published by Springer Nature in Hypertension Research
- Vol. 47 (2) , 1-10
Cognitive impairment in heart failure patients: association with abnormal circadian blood pressure rhythm: a review from the HOPE Asia Network
Cognitive impairment (CI) is frequently a comorbid condition in heart failure (HF) patients, and is associated with increased cardiovascular events and death. Numerous factors contribute to CI in HF patients. Decreased cerebral blood flow, inflammation, and activation of neurohumoral factors are all thought to be factors that exacerbate CI. Hypoperfusion of the brain due to decreased systemic blood flow, cerebral venous congestion, and atherosclerosis are the main mechanism of CI in HF patients. Abnormal circadian BP rhythm is one of the other conditions associated with CI. The conditions in which BP does not decrease sufficiently or increases during the night are called non-dipper or riser BP patterns. Abnormal circadian BP rhythm worsens CI in HF patients through cerebral congestion during sleep and atherosclerosis due to pressure overload. Interventions for CI in HF patients include treatment for HF itself using cardiovascular drugs, and treatment for fluid retention, one of the causes of abnormal circadian rhythms. Proposed pathways of cognitive impairment in heart failure through abnormal circadian blood pressure rhythm.
- 26 September 2023
- Published by Springer Nature in Hypertension Research
- Vol. 47 (2) , 1-10
Cognitive impairment in heart failure patients: association with abnormal circadian blood pressure rhythm: a review from the HOPE Asia Network
Cognitive impairment (CI) is frequently a comorbid condition in heart failure (HF) patients, and is associated with increased cardiovascular events and death. Numerous factors contribute to CI in HF patients. Decreased cerebral blood flow, inflammation, and activation of neurohumoral factors are all thought to be factors that exacerbate CI. Hypoperfusion of the brain due to decreased systemic blood flow, cerebral venous congestion, and atherosclerosis are the main mechanism of CI in HF patients. Abnormal circadian BP rhythm is one of the other conditions associated with CI. The conditions in which BP does not decrease sufficiently or increases during the night are called non-dipper or riser BP patterns. Abnormal circadian BP rhythm worsens CI in HF patients through cerebral congestion during sleep and atherosclerosis due to pressure overload. Interventions for CI in HF patients include treatment for HF itself using cardiovascular drugs, and treatment for fluid retention, one of the causes of abnormal circadian rhythms. Proposed pathways of cognitive impairment in heart failure through abnormal circadian blood pressure rhythm.
- Open Access
- 2 August 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (9)
Unipolar-voltage-based evaluation of left atrial tissue properties and ablation outcome in patients with atrial fibrillation
The relationship between local unipolar voltage (UV) in the pulmonary vein (PV)-ostia and left atrial wall thickness (LAWT) and the utility of these parameters as indices of outcome after atrial fibrillation (AF) ablation remain unclear. Two-hundred seventy-two AF patients who underwent AF ablation were enrolled. Unipolar voltage of PV-ostia was measured using a CARTO system, and LAWT was measured using computed tomography. The primary endpoint was atrial tachyarrhythmia (ATA) recurrence including AF. The ATA recurrence was documented in 74 patients (ATA-Rec group). The UV and LAWT of the bilateral superior PV roof to posterior and around the right-inferior PV in the ATA-Rec group were significantly greater than in patients without ATA recurrence (ATA-Free group) (P < 0.001). The UV had a strong positive correlation with LAWT (R2 = 0.446, P < 0.001). The UV 2.7 mV and the corresponding LAWT 1.6 mm were determined as the cut-off values for ATA recurrence (P < 0.001, respectively). Multisite LA high UV (HUV, ≥4 areas of >2.7 mV) or multisite LA wall thickening (≥5 areas of >1.6 mm), defined as LA hypertrophy (LAH), was related to higher ATA recurrence. Among 92 LAH patients, 66 had HUV (LAH-HUV) and the remaining 26 had low UV (LAH-LUV), characterized by history of non-paroxysmal AF and heart failure, reduced LV ejection fraction, or enlarged LA. In addition, LAH-LUV showed the worst ablation outcome, followed by LAH-HUV and No LAH (log-rank P < 0.001). Combining UV and LAWT enables us to stratify recurrence risk and suggest a tailored ablation strategy according to LA tissue properties.
- 2 August 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (9)
Open AccessUnipolar-voltage-based evaluation of left atrial tissue properties and ablation outcome in patients with atrial fibrillation
The relationship between local unipolar voltage (UV) in the pulmonary vein (PV)-ostia and left atrial wall thickness (LAWT) and the utility of these parameters as indices of outcome after atrial fibrillation (AF) ablation remain unclear. Two-hundred seventy-two AF patients who underwent AF ablation were enrolled. Unipolar voltage of PV-ostia was measured using a CARTO system, and LAWT was measured using computed tomography. The primary endpoint was atrial tachyarrhythmia (ATA) recurrence including AF. The ATA recurrence was documented in 74 patients (ATA-Rec group). The UV and LAWT of the bilateral superior PV roof to posterior and around the right-inferior PV in the ATA-Rec group were significantly greater than in patients without ATA recurrence (ATA-Free group) (P < 0.001). The UV had a strong positive correlation with LAWT (R2 = 0.446, P < 0.001). The UV 2.7 mV and the corresponding LAWT 1.6 mm were determined as the cut-off values for ATA recurrence (P < 0.001, respectively). Multisite LA high UV (HUV, ≥4 areas of >2.7 mV) or multisite LA wall thickening (≥5 areas of >1.6 mm), defined as LA hypertrophy (LAH), was related to higher ATA recurrence. Among 92 LAH patients, 66 had HUV (LAH-HUV) and the remaining 26 had low UV (LAH-LUV), characterized by history of non-paroxysmal AF and heart failure, reduced LV ejection fraction, or enlarged LA. In addition, LAH-LUV showed the worst ablation outcome, followed by LAH-HUV and No LAH (log-rank P < 0.001). Combining UV and LAWT enables us to stratify recurrence risk and suggest a tailored ablation strategy according to LA tissue properties.
- Open Access
- 4 October 2022
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 24 (9) , 1236-1241
The effect of mountaineering on the association between blood pressure and physical activity: A new multi‐sensor ambulatory blood‐pressure monitoring device. The Mount Fuji Study
It has not been fully investigated whether the response of blood pressure (BP) to activity at high altitudes differs from that at low altitudes or how temperature is involved in these differences. The author compared BP response to accelerometer measurements during mountaineering and daily living. In 15 healthy people (mean age 33 ± 6 years), a new multi‐sensor ambulatory BP monitoring (ABPM) device equipped with barometer, thermometer, and accelerometer was used to measure BP responses to activity during a trip to Mt. Fuji and during daily living. Associations between physical activity (log‐transformed 5‐min average values of accelerometer just before each ambulatory BP) and the corresponding BP were obtained from 843 and 676 readings during the Mt. Fuji trip and daily living, respectively. All ambulatory systolic BP (SBP) parameters were significantly higher during the Mt. Fuji trip than during daily living (all p < .01). There were significant positive correlations between physical activity and corresponding BPs in both mountaineering and daily living (all p < .01), and there was an interaction between BPs and physical activity according to the two conditions (p < .01). On Mt. Fuji, multivariate regression analysis showed increased physical activity and lower temperature were associated with increased 24‐h SBP and diastolic BP (DBP) (all p < .05). The goodness‐of‐fit values of the association between activity and 24‐h SBP or DBP were improved by adding temperature to the model of both 24‐h SBP and DBP. However, these associations were not found in the daily living model. BP response to activity was more pronounced during mountaineering than daily living.
- 4 October 2022
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 24 (9) , 1236-1241
Open AccessThe effect of mountaineering on the association between blood pressure and physical activity: A new multi‐sensor ambulatory blood‐pressure monitoring device. The Mount Fuji Study
It has not been fully investigated whether the response of blood pressure (BP) to activity at high altitudes differs from that at low altitudes or how temperature is involved in these differences. The author compared BP response to accelerometer measurements during mountaineering and daily living. In 15 healthy people (mean age 33 ± 6 years), a new multi‐sensor ambulatory BP monitoring (ABPM) device equipped with barometer, thermometer, and accelerometer was used to measure BP responses to activity during a trip to Mt. Fuji and during daily living. Associations between physical activity (log‐transformed 5‐min average values of accelerometer just before each ambulatory BP) and the corresponding BP were obtained from 843 and 676 readings during the Mt. Fuji trip and daily living, respectively. All ambulatory systolic BP (SBP) parameters were significantly higher during the Mt. Fuji trip than during daily living (all p < .01). There were significant positive correlations between physical activity and corresponding BPs in both mountaineering and daily living (all p < .01), and there was an interaction between BPs and physical activity according to the two conditions (p < .01). On Mt. Fuji, multivariate regression analysis showed increased physical activity and lower temperature were associated with increased 24‐h SBP and diastolic BP (DBP) (all p < .05). The goodness‐of‐fit values of the association between activity and 24‐h SBP or DBP were improved by adding temperature to the model of both 24‐h SBP and DBP. However, these associations were not found in the daily living model. BP response to activity was more pronounced during mountaineering than daily living.
- Open Access
- 1 April 2021
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 39 (Supplement) , e99-e100
THE GLOBAL AMBULATORY BLOOD PRESSURE MONITORING (ABPM) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HF-PEF) REGISTRY. RATIONALE, DESIGN AND OBJECTIVES
Objective: The prognosis of patients with heart failure and preserved ejection fraction (HFpEF), depends on multiple factors such as frailty and functional capacity, the presence of comorbidities and haemodynamic parameters including blood pressure (BP). Detailed definition of these prognostic factors may help identify effective management strategies. Our primary objective is to identify measures of BP recorded by ambulatory blood pressure monitoring (ABPM) that associated with hospital readmission due to HF or cardiovascular (CV) death, or functional decline in patients with HFpEF. Secondary objectives will be to examine the association between these measures and each of the components of the primary outcome separately and on non-CV death and all cause death, cognitive impairment and frailty. Design and method: In this prospective observational cohort of patients with stable HFpEF, ABPM will be obtained at baseline and at one year of follow-up. Inclusion criteria will be previous diagnosis of stable HFpEF defined as stable treatment or functional class for at least 4 weeks before study admission. A diagnosis of HFpEF (LVEF > 45%) will be made according to the European Society of Cardiology guidelines. In addition to data on demographics and clinical examination, doppler echocardiography, office BP measurement, ABPM recordings, home BP measurement (HBPM), ECG, laboratory tests (serum creatinine, eGFR, Albumin/Creatinine/Ratio, lipid parameters, glucose, HbA1c, liver biology, albumin, prealbumin, blood cell count, ferritin and transferrin saturation rate, natriuretic peptides) will all be recorded. Functional and cognitive capacity will be assessed using the Barthel index and MOCA test, while frailty will be assessed using the Short Physical Performance Battery, and Frail Phenotype questionnaires. Results: We plan to include data from more than 80 investigators from more than 17 countries around the world during the next 5 years. This study has been registered at https://clinicaltrials.gov/ct2/show/NCT04065620 Conclusions: The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) registry will allow us to assess the association between blood pressure and frailty in a global population of patients with HFPEF
- 1 April 2021
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 39 (Supplement) , e99-e100
Open AccessTHE GLOBAL AMBULATORY BLOOD PRESSURE MONITORING (ABPM) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HF-PEF) REGISTRY. RATIONALE, DESIGN AND OBJECTIVES
Objective: The prognosis of patients with heart failure and preserved ejection fraction (HFpEF), depends on multiple factors such as frailty and functional capacity, the presence of comorbidities and haemodynamic parameters including blood pressure (BP). Detailed definition of these prognostic factors may help identify effective management strategies. Our primary objective is to identify measures of BP recorded by ambulatory blood pressure monitoring (ABPM) that associated with hospital readmission due to HF or cardiovascular (CV) death, or functional decline in patients with HFpEF. Secondary objectives will be to examine the association between these measures and each of the components of the primary outcome separately and on non-CV death and all cause death, cognitive impairment and frailty. Design and method: In this prospective observational cohort of patients with stable HFpEF, ABPM will be obtained at baseline and at one year of follow-up. Inclusion criteria will be previous diagnosis of stable HFpEF defined as stable treatment or functional class for at least 4 weeks before study admission. A diagnosis of HFpEF (LVEF > 45%) will be made according to the European Society of Cardiology guidelines. In addition to data on demographics and clinical examination, doppler echocardiography, office BP measurement, ABPM recordings, home BP measurement (HBPM), ECG, laboratory tests (serum creatinine, eGFR, Albumin/Creatinine/Ratio, lipid parameters, glucose, HbA1c, liver biology, albumin, prealbumin, blood cell count, ferritin and transferrin saturation rate, natriuretic peptides) will all be recorded. Functional and cognitive capacity will be assessed using the Barthel index and MOCA test, while frailty will be assessed using the Short Physical Performance Battery, and Frail Phenotype questionnaires. Results: We plan to include data from more than 80 investigators from more than 17 countries around the world during the next 5 years. This study has been registered at https://clinicaltrials.gov/ct2/show/NCT04065620 Conclusions: The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) registry will allow us to assess the association between blood pressure and frailty in a global population of patients with HFPEF
- Open Access
- 4 February 2021
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 23 (5) , 1089-1092
Quantitative evaluation of white matter hyperintensities in patients with heart failure using an innovative magnetic resonance image analysis method: Association with disrupted circadian blood pressure variation
White matter hyperintensities (WMHs) are risk factors for future cognitive impairment and are associated with an abnormal circadian blood pressure (BP) rhythm in patients with hypertension. However, whether this association exists in patients with heart failure (HF) is unclear. We performed a cross‐sectional study of hospitalized patients with HF who underwent ambulatory BP monitoring and brain magnetic resonance imaging (MRI). A non‐dipper BP pattern was defined as a < 10% nocturnal BP decline. WMHs on brain MRI scans were quantitated using a novel image analysis software (FUSION: FUsed Software for Imaging Of Nervous system). We enrolled 28 hospitalized patients with HF (age: 70.0 ± 9.8 years, 64.3% men). In the brain MRI analysis, the non‐dipper group had higher WMH volume (18.9 ± 19.8 vs. 7.7 ± 8.3 mL, P = .047) and percentage of WMH/total brain volume (1.31 ± 1.28% vs. 0.55 ± 0.58%, P = .04) than the dipper group. In conclusion, using the newly developed MRI analysis software, we successfully quantitatively measured the volume of WMHs and found that the WMH volume increased 2.4 times in patients with a non‐dipper pattern of nocturnal BP compared with those with a normal dipper pattern.
- 4 February 2021
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 23 (5) , 1089-1092
Open AccessQuantitative evaluation of white matter hyperintensities in patients with heart failure using an innovative magnetic resonance image analysis method: Association with disrupted circadian blood pressure variation
White matter hyperintensities (WMHs) are risk factors for future cognitive impairment and are associated with an abnormal circadian blood pressure (BP) rhythm in patients with hypertension. However, whether this association exists in patients with heart failure (HF) is unclear. We performed a cross‐sectional study of hospitalized patients with HF who underwent ambulatory BP monitoring and brain magnetic resonance imaging (MRI). A non‐dipper BP pattern was defined as a < 10% nocturnal BP decline. WMHs on brain MRI scans were quantitated using a novel image analysis software (FUSION: FUsed Software for Imaging Of Nervous system). We enrolled 28 hospitalized patients with HF (age: 70.0 ± 9.8 years, 64.3% men). In the brain MRI analysis, the non‐dipper group had higher WMH volume (18.9 ± 19.8 vs. 7.7 ± 8.3 mL, P = .047) and percentage of WMH/total brain volume (1.31 ± 1.28% vs. 0.55 ± 0.58%, P = .04) than the dipper group. In conclusion, using the newly developed MRI analysis software, we successfully quantitatively measured the volume of WMHs and found that the WMH volume increased 2.4 times in patients with a non‐dipper pattern of nocturnal BP compared with those with a normal dipper pattern.
- 25 November 2020
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 35 (11) , 1029-1037
The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry. Rationale, design and objectives
Hypertension is a major risk factor for the development of heart failure with preserved ejection fraction (HFPEF) and blood pressure (BP) in itself is an important marker of prognosis. The association of BP levels, and hemodynamic parameters, measured by ambulatory blood pressure monitoring (ABPM), with outcomes, in patients with HFPEF is largely unknown. Patients with HFPEF have a substantial burden of co-morbidities and frailty. In addition there are marked geographic differences in HFPEF around the world. How these difference influence the association between BP and outcomes in HFPEF are unknown. The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry aims to assess the relevance of BP parameters, measured by ABPM, on the outcome of HFPEF patients worldwide. Additionally, the influence of other relevant factors such as frailty and co-morbidities will be assessed. Stable HFPEF patients with a previous hospitalization, will be included. Patients should be clinically and hemodynamically stable for at least 4 weeks before study inclusion. Specific data related to HF, biochemical markers, ECG and echocardiography will be collected. An ABPM and geriatric and frailty evaluation will be performed and the association with morbidity and mortality assessed. Follow up will be at least one year.
- 25 November 2020
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 35 (11) , 1029-1037
The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry. Rationale, design and objectives
Hypertension is a major risk factor for the development of heart failure with preserved ejection fraction (HFPEF) and blood pressure (BP) in itself is an important marker of prognosis. The association of BP levels, and hemodynamic parameters, measured by ambulatory blood pressure monitoring (ABPM), with outcomes, in patients with HFPEF is largely unknown. Patients with HFPEF have a substantial burden of co-morbidities and frailty. In addition there are marked geographic differences in HFPEF around the world. How these difference influence the association between BP and outcomes in HFPEF are unknown. The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry aims to assess the relevance of BP parameters, measured by ABPM, on the outcome of HFPEF patients worldwide. Additionally, the influence of other relevant factors such as frailty and co-morbidities will be assessed. Stable HFPEF patients with a previous hospitalization, will be included. Patients should be clinically and hemodynamically stable for at least 4 weeks before study inclusion. Specific data related to HF, biochemical markers, ECG and echocardiography will be collected. An ABPM and geriatric and frailty evaluation will be performed and the association with morbidity and mortality assessed. Follow up will be at least one year.